X

Gilead Sciences, Inc (GILD) Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy

Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release

Newsdesk: